1
Summary: The correct interpretation of biochemical recurrence is crucial to treatment decision-making.
2
Kaplan-Meier estimates of freedom from biochemical recurrence were compared among the groups.
3
The PSA bounce phenomenon was not predictive of time to biochemical recurrence.
4
SSEA-4 expression in post-NHT tissues was significantly associated with biochemical recurrence-free survival.
5
Conclusions: cPSA has high validity for the diagnosis of biochemical recurrence after RP.
6
Kaplan-Meier analysis was used to evaluate the likelihood of biochemical recurrence.
7
We also examined whether the biochemical recurrence rates after RP have changed with time.
8
Cutpoints were identified to define patients with differing risk of biochemical recurrence after RP.
9
Recent findings: There is a disconnection between biochemical recurrence and progression to clinical disease.
10
The risk of biochemical recurrence was not increased for those who received cell-salvaged blood.
11
Subsequently, we examined the relationship between LMW-PTP expression levels and clinicopathological factors including biochemical recurrence.
12
Cox proportional hazard regression models were used to analyse clinicopathological variables associated with biochemical recurrence.
13
Objectives: To evaluate the risk of long-term biochemical recurrence for patients who receive cell-salvaged blood.
14
It also evaluates the array of diagnostic tests frequently employed when biochemical recurrence has occurred.
15
Current imaging modalities are rarely useful in localizing disease when biochemical recurrence is first detected.
16
Conclusions: Preoperative p27 expression is an independent predictor of time to biochemical recurrence following radical prostatectomy.
